Viking Therapeutics VKTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 24.15 | 121.57 | -0.41 | -55,469 | -46 | |
| 2024Q4 | 40.24 | 130.55 | -0.32 | -46,238 | -35 | |
| 2024Q3 | 63.31 | 146.58 | -0.23 | -36,556 | -25 | |
| 2024Q2 | 53.01 | 153.05 | -0.20 | -34,054 | -22 | |
| 2024Q1 | 82.00 | -0.26 | -34,073 | -27 | ||
| 2023Q4 | 18.61 | 119.02 | -0.25 | -29,285 | -25 | |
| 2023Q3 | 11.07 | 120.99 | -0.22 | -27,265 | -23 | |
| 2023Q2 | 16.21 | 123.49 | -0.19 | -23,740 | -19 | |
| 2023Q1 | 16.65 | 105.15 | -0.25 | -20,537 | -20 | |
| 2022Q4 | 9.40 | 103.70 | -0.26 | -20,283 | -20 | |
| 2022Q3 | 2.72 | 102.68 | -0.21 | -16,196 | -16 | |
| 2022Q2 | 2.89 | 101.14 | -0.22 | -17,631 | -17 | |
| 2022Q1 | 3.00 | 100.88 | -0.21 | -16,245 | -16 | |
| 2021Q4 | 4.60 | 101.25 | -0.16 | -12,510 | -12 | |
| 2021Q3 | 6.28 | 101.20 | -0.17 | -13,402 | -13 | |
| 2021Q2 | 5.99 | 101.05 | -0.19 | -15,542 | -15 | |
| 2021Q1 | 6.33 | 101.56 | -0.19 | -14,228 | -14 | |
| 2020Q4 | 5.63 | 102.90 | -0.15 | -11,266 | -11 | |
| 2020Q3 | 5.82 | 105.98 | -0.12 | -9,843 | -9 | |
| 2020Q2 | 7.21 | 110.79 | -0.14 | -10,605 | -10 |